| Molecular Formula | C10H15NO |
| Molar Mass | 165.24 |
| Density | 1.017±0.06 g/cm3(Predicted) |
| Melting Point | 64 °C |
| Boling Point | 170 °C / 31mmHg |
| Flash Point | 114.8°C |
| Solubility | DMSO (Soluble), Methanol (Slightly) |
| Vapor Presure | 0.037Pa at 25℃ |
| Appearance | Solid |
| Color | Off-White to Pale Yellow |
| pKa | 14.24±0.20(Predicted) |
| Storage Condition | Keep in dark place,Inert atmosphere,Room temperature |
| MDL | MFCD00674078 |
| Physical and Chemical Properties | Appearance: white to yellow crystals Melting Point: 59 - 65 ℃ |
| Hazard Symbols | Xn - Harmful![]() |
| Risk Codes | 22 - Harmful if swallowed |
| Safety Description | 36/37 - Wear suitable protective clothing and gloves. |
| WGK Germany | 3 |
| HS Code | 2922199695 |
| LogP | 0.98 |
| introduction | methamphetamine is a pharmaceutical intermediate that can be used to prepare tomoxetine. Tomoxetine, developed by Eli Lilly, is a selective norepinephrine reuptake inhibitor. It is the only non-central nervous stimulant approved by the US FDA for the treatment of attention deficit hyperactivity disorder (ADHD). It is a first-line drug recommended by the American Children and Adolescents Psychiatric Association (AACAP) for the treatment of attention deficit hyperactivity disorder. |